How Quitting Smoking Can Quickly Lower Risk Of A-Fib
Smokers who make the decision to quit will experience immediate health benefits, including a rapid reduction in their risk of atrial fibrillation (A-Fib), according to new research published in JACC: Clinical Electrophysiology. The study, conducted by Dr. Gregory Marcus, a cardiologist at the University of California, San Francisco, offers compelling evidence for smokers to quit, showing that it’s never too late to avoid the damaging effects of smoking on heart health.
Dr. Marcus, the senior author of the study, emphasized that A-Fib can be prevented even in individuals who have smoked for years. "The findings provide a compelling new reason to show current smokers that it’s not too late to quit, and that having smoked in the past doesn’t mean you’re ‘destined’ to develop A-Fib," Marcus explained. "Even for the current and longtime smoker, A-Fib can still be avoided."
"There’s strong evidence that smoking increases the risk of A-Fib," Marcus said. "But the benefits of quitting smoking have been less certain." With this in mind, his team sought to determine whether quitting could significantly lower a person’s risk of developing A-Fib, or if the risk would remain the same.
The research team analyzed data from over 146,700 current and former smokers, tracking their smoking habits and health over a 12-year period using data from the UK Biobank database. The results were promising: former smokers had a 13% lower risk of developing A-Fib compared to current smokers, while those who quit during the study saw an 18% reduction in their risk.
"This is likely a testament to the potency of reducing atrial fibrillation risk pretty shortly after quitting," Marcus said in a statement from the American College of Cardiology.
The findings highlight the importance of quitting smoking, not only for general health but specifically for reducing the risk of serious heart conditions like A-Fib.
Quitting smoking is one of the most effective ways to lower the risk of A-Fib and improve overall heart health. While it can be challenging, the benefits of quitting are clear and immediate. Here are some tips to help you quit smoking successfully:
1. Choose a specific date to quit smoking and stick to it. Prepare yourself mentally and physically for this change.
2. Reach out to family, friends, or a support group to help keep you accountable. Sharing your goals with others can provide encouragement.
3. Options like nicotine patches, gum, or lozenges can help ease withdrawal symptoms and reduce cravings.
4. Identify situations that make you want to smoke, such as stress or social gatherings, and find healthy ways to cope with them.
5. Regular exercise can help distract you from cravings and improve your mood during the quitting process.
6. Drinking water can help flush nicotine out of your system faster, reducing cravings.
7. Activities like yoga, meditation, or deep breathing exercises can help manage stress, a common trigger for smoking.
Quitting smoking offers immediate and significant benefits, particularly in reducing the risk of atrial fibrillation. The latest research provides smokers with more motivation to quit, showing that it's never too late to take control of their heart health.
Credit: CDC
The Cyclospora outbreak that has spread across the US for more than three months has turned deadly, with Michigan—the hardest-hit state—reporting the country's first two deaths linked to the diarrhea-causing parasite.
According to the Michigan Department of Health and Human Services (MDHHS), both individuals had significant underlying health conditions.
"Two deaths have been identified as part of the cyclosporiasis outbreak affecting Michigan. According to medical records, both individuals had significant underlying health conditions that may have been impacted by cyclosporiasis and dehydration," the department said.
Health officials stressed that deaths from cyclosporiasis are rare, as the infection is generally not life-threatening. Michigan has reported 11,234 cases, including 193 hospitalizations.
The US Centers for Disease Control and Prevention (CDC) also confirmed the two outbreak-related deaths in Michigan. As of its July 28 update, the agency has recorded 6,707 laboratory-confirmed cases across 45 states since May 1, along with more than 11,500 suspected cases—primarily in Michigan and Ohio—that are yet to be laboratory confirmed. The outbreak has resulted in 423 hospitalizations.
The US Food and Drug Administration (FDA) has linked part of the outbreak to iceberg lettuce supplied by Taylor Farms de Mexico. The company voluntarily recalled affected products on July 17 and said it will no longer source iceberg lettuce from central Mexico for the rest of the growing season.
The recalled lettuce has been linked to illnesses in Indiana, Kentucky, Michigan, Ohio, and West Virginia. Separately, the CDC, FDA, and state health officials are investigating another Cyclospora outbreak linked to iceberg lettuce in nine states, which has sickened at least 1,947 people and hospitalized 98.
Officials are also investigating whether parsley and cilantro may be linked to the outbreak.
Cyclospora is a parasite that infects the intestines and is usually spread through contaminated food or water.
Most infections are mild and resolve without treatment. However, the illness can be prolonged or severe in people with weakened immune systems, who may require antibiotic treatment.
If you develop symptoms:
Doctors diagnose cyclosporiasis with a stool test that detects the Cyclospora parasite shed in stool.
Although some mild infections may resolve on their own, confirmed cases should be treated with antibiotics. The recommended treatment is the antibiotic trimethoprim/sulfamethoxazole (TMP-SMX).
Your doctor may also recommend:
Credit: AI
An 86-year-old sheep farmer from Wales recently shared how he unknowingly lived with a rare parasitic disease for years before experiencing what he described as "the worst pain" of his life.
The rare case has highlighted a little-known infection that experts say can remain hidden inside the body for decades.
Meredydd Jones, from Trecastle in Powys, was diagnosed with hydatid disease, a parasitic infection caused by the tapeworm Echinococcus granulosus.
He said that slow-growing cysts had been developing in his lungs for years before he was rushed to the hospital after he complained of severe pain in 2016.
"I hadn't been able to control the pain, and it was more intense than anything I had before," Jones recalled. He later underwent two surgeries in 2018 and 2019 to remove cysts from both lungs, while another cyst in his liver continues to be monitored.
The case comes as Public Health Wales raise concerns that the disease, though uncommon, remains a significant public health issue in sheep-farming regions.
Hydatid disease, also known as cystic echinococcosis, is caused by the larval stage of the Echinococcus tapeworm.
The parasite typically circulates between dogs and livestock such as sheep and cattle. Humans become accidental hosts after ingesting microscopic tapeworm eggs, usually through contact with infected dogs or contaminated food, water, or soil.
Unlike many infections, hydatid disease develops very slowly and gradually. The parasite forms fluid-filled cysts that most commonly affect the liver and lungs, although they can also develop in the brain, bones, or other organs.
According to Dr Chris Williams, consultant epidemiologist at Public Health Wales, the disease can remain hidden for an unusually long time.
"What happens is normally the tapeworm transmits between farm animals like sheep and cows to dogs, and the dogs excrete eggs," he explained. "Unfortunately, if humans ingest the eggs, they can then form cysts within humans."
He added that symptoms may not appear for 10 to 20 years, which is why infections are often discovered only after cysts become large enough to cause complications. Depending on where the cysts develop, people may experience:
Public Health Wales says hydatid disease is uncommon but can have serious health consequences if left untreated.
Researchers at Aberystwyth University are now studying dogs, livestock and farming practices to better understand whether the parasite is emerging again in parts of Wales.
The project includes analysing dog faecal samples and tracking farm dogs to understand how the parasite may spread between farms. Experts say prevention remains the most effective strategy.
Regular deworming of dogs, proper disposal of livestock carcasses, avoiding feeding dogs raw offal, and practising good hand hygiene after handling animals can significantly reduce the risk of infection.
Credit: AI image
The deadly and highly contagious disease smallpox, eradicated worldwide in 1980 through vaccination, was introduced to the Americas by Europeans, according to a new study that analyzed DNA from 500-year-old Inca mummies.
Smallpox, caused by the variola virus, played a major role in the devastating population decline among Indigenous people in the Americas following the arrival of Christopher Columbus in 1492.
Historians have long believed that smallpox reshaped societies and killed millions worldwide. However, direct genetic evidence linking European strains to outbreaks in the Americas had been lacking.
Dr. Shigeki Nakagome from Trinity College Dublin's School of Medicine said the findings provide "the first molecular confirmation that smallpox was carried to the Americas during the colonial period."
The researchers added that the findings could also help improve understanding of how pathogens evolve, with potential relevance for diseases such as influenza, COVID-19 and mpox.
Published in the journal Science, the researchers sequenced ancient smallpox DNA from two individuals buried in northern Chile between 1492 and 1631 CE, during the transition from the Inca to the colonial period.
The analysis showed that the viruses belonged to a now-extinct lineage of the variola virus, closely related to ancient European strains that disappeared before the 20th century. These are the earliest smallpox genomes recovered from the Americas, providing a clearer timeline of the virus's evolution.
Researchers also noted that skin lesions previously thought to result from arsenic exposure are consistent with smallpox infection.
The team identified the same viral strain in multiple individuals of Native American ancestry, suggesting local transmission within Indigenous communities during the colonial era.
The study also provides new insights into how the virus evolved over time.
"We found that the virus underwent a long period of genetic change up to the 16th century, but its evolution slowed markedly during the height of colonial expansion and major smallpox epidemics in the 17th and 18th centuries," said Dr. Lara Cassidy from Trinity College Dublin's School of Genetics and Microbiology.
She said the virus may have reached an evolutionary optimum, allowing it to spread efficiently with little further adaptation, likely aided by the lack of immunity in newly exposed populations.
The researchers also found evidence that this period of evolutionary stability may have ended in the 19th century as vaccination became widespread. As immunity increased, the pace of viral evolution appears to have accelerated again.
Bruno Romero González, a PhD student at Trinity College Dublin's School of Medicine, said the findings show how colonization, population change and vaccination likely shaped the evolution of one of humanity's most devastating infectious diseases.
The study also demonstrates the power of ancient pathogen genomics, showing how ancient DNA can uncover aspects of disease history that are not preserved in historical records.
Smallpox spread mainly through respiratory droplets released during coughing, sneezing or close contact. The disease caused fever followed by a characteristic rash that developed into fluid-filled blisters and scabs.
About 3 in 10 infected people died, while many survivors were left with permanent scars, particularly on the face. Some also lost their vision. Following a global vaccination campaign, smallpox was declared eradicated in 1980, with the last naturally occurring case reported in 1977.
© 2024 Bennett, Coleman & Company Limited